ALAMEDA, Calif., Oct. 17 /PRNewswire-FirstCall/ -- Avigen, Inc. (Nasdaq: AVGN - News) a biopharmaceutical company developing innovative therapies for the treatment of neurological conditions, announced today that Chief Business Officer Michael Coffee will present an overview of the Company at the BIO InvestorForum 2006 Conference:
